George Bou-Assaf
Company: Biogen
Job title: Associate Director, Analytical Development
Seminars:
Chair’s Closing Remarks 3:45 pm
day: Day Two
Chair’s Opening Remarks 9:20 am
day: Day Two
Roundtable Discussion: How Are Biopharma Companies Currently Navigating the Regulatory Landscape? 3:00 pm
• Are sponsors successful with using the purge argument to justify the omission of tests to monitor small molecule process-related impurities and residual solvents? • Considering more complex oligonucleotides and conjugates – what factors have sponsors considered and what feedback have they received from regulators? • What are the next generation of analytical methods used…Read more
day: Day One